Vident Advisory’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.7M Buy
154,186
+12,749
+9% +$3.8M 0.36% 53
2025
Q4
$46.7M Buy
141,437
+8,119
+6% +$2.75M 0.43% 52
2025
Q3
$46M Buy
133,318
+6,473
+5% +$1.96M 0.44% 47
2025
Q2
$39.6M Buy
126,845
+37,979
+43% +$14.5M 0.44% 48
2025
Q1
$46.5M Buy
88,866
+7,834
+10% +$4M 0.68% 27
2024
Q4
$41M Buy
81,032
+68,536
+548% +$38.9M 0.72% 24
2024
Q3
$7.31M Sell
12,496
-22,994
-65% -$13M 0.18% 106
2024
Q2
$18.1M Sell
35,490
-106,920
-75% -$52.4M 0.5% 37
2024
Q1
$70.5M Buy
142,410
+33,581
+31% +$17.1M 1.47% 1
2023
Q4
$57.3M Buy
108,829
+7,241
+7% +$3.86M 1.44% 3
2023
Q3
$51.2M Buy
+101,588
New +$50M 1.59% 2

Other funds holding UNH

Vident Advisory's UNH Position: Q1 2026 in Review

Vident Advisory increased its UnitedHealth (UNH) stake by 9% in Q1 2026, buying an estimated $3.8M and bringing the position to 154,186 shares worth $41.7M. The position accounts for 0.36% of the portfolio, ranked #53.

Vident Advisory first reported a position in UNH in Q3 2023 and has held it in 11 quarters since. The position peaked at $70.5M in Q1 2024. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Vident Advisory held 154,186 shares of UnitedHealth worth $41.7M as of Q1 2026.
  • Vident Advisory bought 12,749 UnitedHealth shares in Q1 2026, an estimated $3.8M.
  • UnitedHealth made up 0.36% of Vident Advisory's portfolio in Q1 2026, its #53 holding.
  • Vident Advisory first reported a position in UnitedHealth in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's UnitedHealth position peaked at $70.5M in Q1 2024.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.